Literature DB >> 7681204

Growth of an androgen-sensitive human prostate cancer cell line, LNCaP, in nude mice.

D J Lim1, X L Liu, D M Sutkowski, E J Braun, C Lee, J M Kozlowski.   

Abstract

This study was undertaken to establish an androgen-sensitive model of human prostatic carcinoma in nude mice. The androgen-sensitive prostatic carcinoma cell line, LNCaP, was suspended in reconstituted basement membrane (Matrigel) and injected subcutaneously into nude mice. The LNCaP cell line was chosen for the study, because the cell line is androgen-sensitive and secretes prostate specific antigen (PSA) into culture media. Following injection of 1 x 10(6) LNCaP cells with 0.25 ml of Matrigel, 88% of mice exhibited palpable tumor burdens after 12 weeks of observation. In addition, significant levels of PSA were observed in the serum of LNCaP-bearing mice. Bilateral orchiectomy of mice resulted in tumor regression and stabilization of serum PSA levels, compared to testis-intact controls. A significant correlation of PSA to tumor volume and weight was observed. The castrate level of testosterone was confirmed by radioimmunoassay and was similar to testosterone levels in female nude mice. Matrigel allows for a conducive environment to propagate LNCaP cells in nude mice. Furthermore, the growth can be manipulated by castration, leading to involution of tumor and stabilization of serum PSA level. This in vivo model of hormone-sensitive human prostate cancer cell line will serve as a model for the study of prostate tumor biology and treatment.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7681204     DOI: 10.1002/pros.2990220203

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  21 in total

1.  A novel method for implantation of LNCaP prostate tumor cells under the renal capsule.

Authors:  R M Adam; A Orsola; M R Freeman
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-06       Impact factor: 2.416

Review 2.  Development of patient-derived xenograft models of prostate cancer for maintaining tumor heterogeneity.

Authors:  Changhong Shi; Xue Chen; Dengxu Tan
Journal:  Transl Androl Urol       Date:  2019-10

3.  The smooth muscle gamma-actin gene is androgen responsive in prostate epithelia.

Authors:  R A Filmore; D A Dean; W E Zimmer
Journal:  Gene Expr       Date:  2002

4.  Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells.

Authors:  B B Moore; D A Arenberg; K Stoy; T Morgan; C L Addison; S B Morris; M Glass; C Wilke; Y Y Xue; S Sitterding; S L Kunkel; M D Burdick; R M Strieter
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

Review 5.  Current mouse and cell models in prostate cancer research.

Authors:  Xinyu Wu; Shiaoching Gong; Pradip Roy-Burman; Peng Lee; Zoran Culig
Journal:  Endocr Relat Cancer       Date:  2013-06-24       Impact factor: 5.678

6.  Characterization of a novel metastatic prostate cancer cell line of LNCaP origin.

Authors:  Mark A Castanares; Ben T Copeland; Wasim H Chowdhury; Minzhi M Liu; Ronald Rodriguez; Martin G Pomper; Shawn E Lupold; Catherine A Foss
Journal:  Prostate       Date:  2015-10-26       Impact factor: 4.104

7.  Distinct nuclear and cytoplasmic functions of androgen receptor cofactor p44 and association with androgen-independent prostate cancer.

Authors:  Yi Peng; Fei Chen; Jonathan Melamed; Luis Chiriboga; Jianjun Wei; Xiangtian Kong; Maureen McLeod; Yirong Li; Caihong X Li; Alice Feng; Michael J Garabedian; Zhengxin Wang; Robert G Roeder; Peng Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-20       Impact factor: 11.205

8.  5α-reductase inhibition suppresses testosterone-induced initial regrowth of regressed xenograft prostate tumors in animal models.

Authors:  Khalid Z Masoodi; Raquel Ramos Garcia; Laura E Pascal; Yujuan Wang; Hei M Ma; Katherine O'Malley; Kurtis Eisermann; Daniel H Shevrin; Holly M Nguyen; Robert L Vessella; Joel B Nelson; Rahul A Parikh; Zhou Wang
Journal:  Endocrinology       Date:  2013-05-13       Impact factor: 4.736

9.  Ligand-independent activation of androgen receptors by Rho GTPase signaling in prostate cancer.

Authors:  Leah S Lyons; Shuyun Rao; Wayne Balkan; Joanne Faysal; Carol A Maiorino; Kerry L Burnstein
Journal:  Mol Endocrinol       Date:  2007-12-13

Review 10.  In vivo and in vitro approaches to study metastasis in human prostatic cancer.

Authors:  C Lee; D H Shevrin; J M Kozlowski
Journal:  Cancer Metastasis Rev       Date:  1993-03       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.